It is interesting that low MUC2 expression showed a preferential relationship with the left-sided colon cancer and indicated a short disease-free survival (DFS) and disease-specific survival (DSS), suggesting that MUC2 may be a potential biomarker for differentiating left/right colon cancer and evaluating the prognosis of patients. Here, MUC2 is linked to malignant colon neoplasm.